Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8OWT

SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound

これはPDB形式変換不可エントリーです。
8OWT の概要
エントリーDOI10.2210/pdb8owt/pdb
分子名称Nanobody A8, Spike protein S1, Nanobody H3, ... (6 entities in total)
機能のキーワードnanobody, complex, receptor binding domain, sars-cov-2, viral protein
由来する生物種Lama glama
詳細
タンパク質・核酸の鎖数6
化学式量合計107302.55
構造登録者
Mikolajek, H.,Naismith, J.H.,Owens, R.J. (登録日: 2023-04-28, 公開日: 2024-05-08, 最終更新日: 2024-11-06)
主引用文献Cornish, K.,Huo, J.,Jones, L.,Sharma, P.,Thrush, J.W.,Abdelkarim, S.,Kipar, A.,Ramadurai, S.,Weckener, M.,Mikolajek, H.,Liu, S.,Buckle, I.,Bentley, E.,Kirby, A.,Han, X.,Laidlaw, S.M.,Hill, M.,Eyssen, L.,Norman, C.,Le Bas, A.,Clarke, J.,James, W.,Stewart, J.P.,Carroll, M.,Naismith, J.H.,Owens, R.J.
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.
Open Biology, 14:230252-230252, 2024
Cited by
PubMed Abstract: The Omicron strains of SARS-CoV-2 pose a significant challenge to the development of effective antibody-based treatments as immune evasion has compromised most available immune therapeutics. Therefore, in the 'arms race' with the virus, there is a continuing need to identify new biologics for the prevention or treatment of SARS-CoV-2 infections. Here, we report the isolation of nanobodies that bind to the Omicron BA.1 spike protein by screening nanobody phage display libraries previously generated from llamas immunized with either the Wuhan or Beta spike proteins. The structure and binding properties of three of these nanobodies (A8, H6 and B5-5) have been characterized in detail providing insight into their binding epitopes on the Omicron spike protein. Trimeric versions of H6 and B5-5 neutralized the SARS-CoV-2 variant of concern BA.5 both and in the hamster model of COVID-19 following nasal administration. Thus, either alone or in combination could serve as starting points for the development of new anti-viral immunotherapeutics.
PubMed: 38835241
DOI: 10.1098/rsob.230252
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.37 Å)
構造検証レポート
Validation report summary of 8owt
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon